Quinupristin + Dalfopristin
Paul G. Auwaerter, M.D.
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Patients with serious or life-threatening infections associated with vancomycin-resistant
Enterococcus faecium
(VREF) bacteremia.
Complicated skin and skin structure infections caused by
Staphylococcus aureus
(MSSA) or
Streptococcus pyogenes
.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Endocarditis
(generally not recommended due to poorer clearance of bacteremia)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved